Cardiac resynchronization therapy (CRT) improves cardiac function in patients with heart failure (HF), and the result of this treatment is decrease in death rate and improving quality of life for patients. This research is aimed at predicting CRT response for the prognosis of patients with heart failure under CRT. According to international instructions, in the case of approval of QRS prolongation and decrease in ejection fraction (EF), the patient is recognized as a candidate of implanting recognition device. However, regarding many intervening and effective factors, decision making can be done based on more variables. Computer-based decision-making systems especially machine learning (ML) are considered as a promising method regarding their significant background in medical prediction. Collective intelligence approaches such as particles swarm optimization (PSO) algorithm are used for determining the priorities of medical decision-making variables. This investigation was done on 209 patients and the data was collected over 12 months. In HESHMAT CRT center, 17.7% of patients did not respond to treatment. Recognizing the dominant parameters through combining machine recognition and physician's viewpoint, and introducing back-propagation of error neural network algorithm in order to decrease classification error are the most important achievements of this research. In this research, an analytical set of individual, clinical, and laboratory variables, echocardiography, and electrocardiography (ECG) are proposed with patients' response to CRT. Prediction of the response after CRT becomes possible by the support of a set of tools, algorithms, and variables.
Cardiac resynchronization therapy (CRT) improves cardiac function in patients with heart failure (HF), and the result of this treatment is decrease in death rate and improving quality of life for patients. This research is aimed at predicting CRT response for the prognosis of patients with heart failure under CRT. According to international instructions, in the case of approval of QRS prolongation and decrease in ejection fraction (EF), the patient is recognized as a candidate of implanting recognition device. However, regarding many intervening and effective factors, decision making can be done based on more variables. Computer-based decision-making systems especially machine learning (ML) are considered as a promising method regarding their significant background in medical prediction. Collective intelligence approaches such as particles swarm optimization (PSO) algorithm are used for determining the priorities of medical decision-making variables. This investigation was done on 209 patients and the data was collected over 12 months. In HESHMAT CRT center, 17.7% of patients did not respond to treatment. Recognizing the dominant parameters through combining machine recognition and physician's viewpoint, and introducing back-propagation of error neural network algorithm in order to decrease classification error are the most important achievements of this research. In this research, an analytical set of individual, clinical, and laboratory variables, echocardiography, and electrocardiography (ECG) are proposed with patients' response to CRT. Prediction of the response after CRT becomes possible by the support of a set of tools, algorithms, and variables.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.